p75NTR screening assay for indentifying modulators of apoptosis

Details for Australian Patent Application No. 2005261721 (hide)

Owner Janssen Pharmaceutica N.V.

Inventors Bruinzeel, Wouter David; Cik, Miroslav

Agent Shelston IP

Pub. Number AU-B-2005261721

PCT Pub. Number WO2006/005740

Priority 04103368.9 14.07.04 EP; 60/588,551 16.07.04 US

Filing date 11 July 2005

Wipo publication date 19 January 2006

Acceptance publication date 24 February 2011

International Classifications

C12N 15/88 (2006.01) Mutation or genetic engineering

G01N 33/50 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Chemical analysis of biological material, e.g. blood, urine

Event Publications

1 March 2007 PCT application entered the National Phase

  PCT publication WO2006/005740 Priority application(s): WO2006/005740

24 February 2011 Application Accepted

  Published as AU-B-2005261721

23 June 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005261727-Treating liquefied natural gas

2005261705-Catalysts for fuel cell electrodes based on platinum and its alloys, the preparation and use thereof, as well as fuel cells containing them